Rybelsus

PCOS

University of Colorado, DenverPhase 2/3Dormant

B

60/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 46/ 100
Competitive Position: 89/ 100

Competitive context

66 Active assets in the PCOS cohort.

Asset / Sponsor	Phase	Rating
Hcg Eman Basuni Ebrahim Mowad	Phase 4	BBB
Liraglutide Peking University Third Hospital	Phase 4	BBB
Semaglutide Methodist Health System	Phase 4	BBB
FOLLITROPIN BETA Universitair Ziekenhuis Brussel	Phase 4	BBB
Drospirenone Ege University	Phase 4	BBB

View all 50 →

Same molecule, other indications

Rybelsus is also rated in:

metabolic dysfunction-associated steatotic liver diseaseDormant

BB

Indicative ·

68 / 100

obesity disorderDormant

BB

Indicative ·

67 / 100

diabetes mellitusDormant

CCC

Indicative ·

53 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.